Ethambutol is an antibiotic used to treat tuberculosis (TB). It is a first-line TB drug and is often used in combination with other drugs. Ethambutol is available as a generic drug and is also sold under the brand names Myambutol and E.P. Myambutol. The global market for ethambutol is expected to grow at a CAGR of 5.5% from 2022 to 2028. The growth of the market is driven by the increasing prevalence of TB, the rising incidence of drug-resistant TB, and the growing demand for generic drugs. This article provides a list of global buyers of ethambutol. The list includes pharmaceutical companies, wholesalers, and distributors. The list is updated regularly…